Biologics Top Stories Bone Therapeutics SA and Asahi Kasei sign exclusive license agreement for PREOB® in Japan byJosh SandbergSeptember 22, 2017
Biologics Bone Therapeutics Reports Initial Efficacy Results from Its PREOB® Phase IIA Trial in Severe Osteoporosis byJosh SandbergMarch 30, 2016
Recon Bone Therapeutics Reports First Results of Its Phase IIA Trial for PREOB® in Severe Osteoporosis byJosh SandbergJune 22, 2015
